G T. De Vries-Los

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma.

Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma.

Journal: Nature communications
Published: July 22, 2024

Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell.

Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell.

Journal: Cancer research
Published: December 05, 2022

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.

Journal: HemaSphere
Published: October 27, 2022

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.

Journal: Blood advances
Published: June 24, 2022

The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice.

The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice.

Journal: Frontiers in oncology
Published: June 15, 2022

Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing.

Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing.

Journal: Nature communications
Published: December 04, 2020

Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.

Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.

Journal: Blood
Published: February 14, 2020

Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma.

Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma.

Journal: Blood
Published: December 05, 2018

An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential.

An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential.

Journal: Cell
Published: October 06, 2017
Showing 1-9 of 9

Last Updated: 09/26/2026